Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States
Xuehua Ke(Wilmington University), Lisa A. Beck(University of Rochester Medicine), Vincent J. Willey(Wilmington University), Judith J. Stephenson(Wilmington University), Qing Huang(Chinese Academy of Sciences), Benjamin Ortiz(Harlem Hospital Center), Brandee Paknis(Novartis (United States)), Jonathan A. Bernstein(Bernstein Clinical Research Center), Liya Wang(Wilmington University), Abhishek Kavati(Pfizer (United States)), Debra Wertz(Wilmington University)
Cited by 13
Related Papers
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Graphene-Based Antibacterial Paper
|ACS Nano|2010|2k
A general Lewis acidic etching route for preparing MXenes with enhanced electrochemical performance in non-aqueous electrolyte
|Nature Materials|2020|1.6k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k